Education
About Us
Working with TipRanks
Follow Us
CAMP4 Therapeutics Corporation (CAMP)
NASDAQ:CAMP
RESEARCH TOOLSreports
Total Valuation
CAMP4 Therapeutics Corporation has a market cap or net worth of $29.23M. The enterprise value is $3.74B.
Market Cap$29.23M
Enterprise Value$3.74B
Share Statistics
CAMP4 Therapeutics Corporation has 20,161,074 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding20,161,074
Owned by Insiders79.64%
Owned by Institutions―
Financial Efficiency
CAMP4 Therapeutics Corporation’s return on equity (ROE) is -0.82 and return on invested capital (ROIC) is -73.94%.
Return on Equity (ROE)-0.82
Return on Assets (ROA)-0.66
Return on Invested Capital (ROIC)-73.94%
Return on Capital Employed (ROCE)-0.77
Revenue Per Employee11.85K
Profits Per Employee-941.65K
Employee Count55
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of CAMP4 Therapeutics Corporation is -1.97. CAMP4 Therapeutics Corporation’s PEG ratio is -48.01.
PE Ratio-1.97
PS Ratio0.00
PB Ratio247.81
Price to Fair Value1.61
Price to FCF-104.18
Price to Operating Cash Flow-154.60
PEG Ratio-48.01
Income Statement
In the last 12 months, CAMP4 Therapeutics Corporation had revenue of 652.00K and earned -51.79M in profits. Earnings per share was -2.66.
Revenue652.00K
Gross Profit652.00K
Operating Income-53.09M
Pretax Income-51.79M
Net Income-51.79M
EBITDA-51.39M
Earnings Per Share (EPS)-2.66
Cash Flow
In the last 12 months, operating cash flow was -48.70M and capital expenditures -705.00K, giving a free cash flow of -49.41M billion.
Operating Cash Flow-48.70M
Free Cash Flow-49.41M
Free Cash Flow per Share-2.45
Dividends & Yields
CAMP4 Therapeutics Corporation pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.68
52-Week Price Change-85.13%
50-Day Moving Average1.96
200-Day Moving Average―
Relative Strength Index (RSI)26.62
Average Volume (3m)561.06K
Important Dates
CAMP4 Therapeutics Corporation upcoming earnings date is May 13, 2025, TBA Not Confirmed.
Last Earnings DateMar 27, 2025
Next Earnings DateMay 13, 2025
Ex-Dividend Date―
Financial Position
CAMP4 Therapeutics Corporation as a current ratio of 6.92, with Debt / Equity ratio of 1680.54%
Current Ratio6.92
Quick Ratio6.92
Debt to Market Cap0.03
Net Debt to EBITDA1.08
Interest Coverage Ratio0.00
Taxes
In the past 12 months, CAMP4 Therapeutics Corporation has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
CAMP4 Therapeutics Corporation EV to EBITDA ratio is -0.90, with an EV/FCF ratio of -1.01.
EV to Sales71.21
EV to EBITDA-0.90
EV to Free Cash Flow-1.01
EV to Operating Cash Flow-1.02
Balance Sheet
CAMP4 Therapeutics Corporation has $49.32M in cash and marketable securities with $7.87M in debt, giving a net cash position of -$41.45M billion.
Cash & Marketable Securities$49.32M
Total Debt$7.87M
Net Cash-$41.45M
Net Cash Per Share-$2.06
Tangible Book Value Per Share$3.24
Margins
Gross margin is 36.96%, with operating margin of -8142.33%, and net profit margin of -7943.40%.
Gross Margin36.96%
Operating Margin-8142.33%
Pretax Margin-7943.40%
Net Profit Margin-7943.40%
EBITDA Margin-7882.21%
EBIT Margin-8142.33%
Analyst Forecast
The average price target for CAMP4 Therapeutics Corporation is $15.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$15.25
Price Target Upside951.72% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast―
EPS Growth Forecast―